HomeCompareUMTAF vs PLD

UMTAF vs PLD: Dividend Comparison 2026

UMTAF yields 58.82% · PLD yields 3.18%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 UMTAF wins by $19367.77M in total portfolio value
10 years
UMTAF
UMTAF
● Live price
58.82%
Share price
$0.60
Annual div
$0.35
5Y div CAGR
41.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$19374.28M
Annual income
$17,550,348,472.66
Full UMTAF calculator →
PLD
PLD
● Live price
3.18%
Share price
$128.78
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.50M
Annual income
$5,256,436.18
Full PLD calculator →

Portfolio growth — UMTAF vs PLD

📍 UMTAF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodUMTAFPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, UMTAF + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
UMTAF pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

UMTAF
Annual income on $10K today (after 15% tax)
$5,000.00/yr
After 10yr DRIP, annual income (after tax)
$14,917,796,201.76/yr
PLD
Annual income on $10K today (after 15% tax)
$270.62/yr
After 10yr DRIP, annual income (after tax)
$4,467,970.75/yr
At 15% tax rate, UMTAF beats the other by $14,913,328,231.01/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of UMTAF + PLD for your $10,000?

UMTAF: 50%PLD: 50%
100% PLD50/50100% UMTAF
Portfolio after 10yr
$9690.39M
Annual income
$8,777,802,454.42/yr
Blended yield
90.58%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

UMTAF
No analyst data
Altman Z
1.2
Piotroski
6/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+5.6% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

UMTAF buys
0
PLD buys
0
No recent congressional trades found for UMTAF or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricUMTAFPLD
Forward yield58.82%3.18%
Annual dividend / share$0.35$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR41.5%74.4%
Portfolio after 10y$19374.28M$6.50M
Annual income after 10y$17,550,348,472.66$5,256,436.18
Total dividends collected$19239.07M$6.37M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: UMTAF vs PLD ($10,000, DRIP)

YearUMTAF PortfolioUMTAF Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$19,024$8,323.53$11,255$555.24+$7.8KUMTAF
2$41,295$20,939.74$13,062$1,018.59+$28.2KUMTAF
3$104,296$60,110.37$15,903$1,926.67+$88.4KUMTAF
4$312,364$200,767.26$20,839$3,823.32+$291.5KUMTAF
5$1,129,398$795,168.21$30,464$8,166.08+$1.10MUMTAF
6$5,010,504$3,802,048.80$52,054$19,457.30+$4.96MUMTAF
7$27,667,405$22,306,165.71$109,886$54,188.93+$27.56MUMTAF
8$192,490,433$162,886,309.88$304,030$186,451.18+$192.19MUMTAF
9$1,704,606,994$1,498,642,230.13$1,166,125$840,813.32+$1703.44MUMTAF
10$19,374,277,956$17,550,348,472.66$6,504,190$5,256,436.18+$19367.77MUMTAF

UMTAF vs PLD: Complete Analysis 2026

UMTAFStock

Genertec Universal Medical Group Company Limited, together with its subsidiaries, offers financing and advisory services in the People's Republic of China. It operates in two segments, Finance and Advisory and Hospital Group. The Finance and Advisory segment provides direct finance leasing; sale and leaseback; factoring; operating leases; and advisory services. The Hospital Group segment engages in the provision of medical services; hospital and healthcare management; and import and export trading businesses, as well as trading of medical-related goods. The company is also involved in the provision of medical technology; hospital digitalization, construction, and management services; property management; and medical consulting services. It serves patients, hospitals, medical equipment suppliers, and other public institutions. The company was formerly known as Universal Medical Financial & Technical Advisory Services Company Limited and changed its name to Genertec Universal Medical Group Company Limited in July 2018. Genertec Universal Medical Group Company Limited was founded in 1984 and is headquartered in Beijing, China.

Full UMTAF Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this UMTAF vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

UMTAF vs SCHDUMTAF vs JEPIUMTAF vs OUMTAF vs KOUMTAF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.